GE HEALTHCARE TECH.INC. (F:L0T) — Market Cap & Net Worth
Market Cap & Net Worth: GE HEALTHCARE TECH.INC. (L0T)
GE HEALTHCARE TECH.INC. (F:L0T) has a market capitalization of $27.21 Billion (€23.27 Billion) as of May 2, 2026. Listed on the F stock exchange, this Germany-based company holds position #960 globally and #220 in its home market, demonstrating a -15.92% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying GE HEALTHCARE TECH.INC.'s stock price €51.06 by its total outstanding shares 455749767 (455.75 Million).
GE HEALTHCARE TECH.INC. Market Cap History: 2023 to 2026
GE HEALTHCARE TECH.INC.'s market capitalization history from 2023 to 2026. Data shows change from $36.97 Billion to $27.21 Billion (-3.18% CAGR).
GE HEALTHCARE TECH.INC. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how GE HEALTHCARE TECH.INC.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of L0T by Market Capitalization
Companies near GE HEALTHCARE TECH.INC. in the global market cap rankings as of May 2, 2026.
Key companies related to GE HEALTHCARE TECH.INC. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #140 globally with a market cap of $157.87 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #196 globally with a market cap of $120.60 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #234 globally with a market cap of $103.80 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #140 | Abbott Laboratories | NYSE:ABT | $157.87 Billion | $90.79 |
| #196 | Stryker Corporation | NYSE:SYK | $120.60 Billion | $315.13 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #234 | Medtronic PLC | NYSE:MDT | $103.80 Billion | $80.97 |
GE HEALTHCARE TECH.INC. Historical Marketcap From 2023 to 2026
Between 2023 and today, GE HEALTHCARE TECH.INC.'s market cap moved from $36.97 Billion to $ 27.21 Billion, with a yearly change of -3.18%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €27.21 Billion | -27.14% |
| 2025 | €37.34 Billion | -8.15% |
| 2024 | €40.65 Billion | +9.96% |
| 2023 | €36.97 Billion | -- |
End of Day Market Cap According to Different Sources
On May 1st, 2026 the market cap of GE HEALTHCARE TECH.INC. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $27.21 Billion USD |
| MoneyControl | $27.21 Billion USD |
| MarketWatch | $27.21 Billion USD |
| marketcap.company | $27.21 Billion USD |
| Reuters | $27.21 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About GE HEALTHCARE TECH.INC.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical… Read more